These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6326711)

  • 1. Neurovirulence of an herpes simplex type 1 thymidine kinase negative mutant determined by virus biochemical defect and host immune system in mice. Brief report.
    Gordon YJ; Simon PL; Armstrong JA
    Arch Virol; 1984; 80(2-3):225-9. PubMed ID: 6326711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymidine Kinase-Negative Herpes Simplex Virus 1 Can Efficiently Establish Persistent Infection in Neural Tissues of Nude Mice.
    Huang CY; Yao HW; Wang LC; Shen FH; Hsu SM; Chen SH
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27974554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppression promotes ocular virus replication and CNS neurovirulence following corneal inoculation with an avirulent herpes simplex type 1 thymidine kinase negative mutant.
    Gordon YJ; Rao H; Arullo-Cruz T
    Curr Eye Res; 1984 Apr; 3(4):651-7. PubMed ID: 6325093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurovirulence of herpes simplex virus type 1 depends on age in mice and thymidine kinase expression.
    Ben-Hur T; Hadar J; Shtram Y; Gilden DH; Becker Y
    Arch Virol; 1983; 78(3-4):303-8. PubMed ID: 6318700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization of a herpes simplex virus neurovirulence gene dissociated from high-titer virus replication in the brain.
    Javier RT; Izumi KM; Stevens JG
    J Virol; 1988 Apr; 62(4):1381-7. PubMed ID: 2831400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The RL neurovirulence locus in herpes simplex virus type 2 strain HG52 plays no role in latency.
    MacLean A; Robertson L; McKay E; Brown SM
    J Gen Virol; 1991 Sep; 72 ( Pt 9)():2305-10. PubMed ID: 1654382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complementary lethal invasion of the central nervous system by nonneuroinvasive herpes simplex virus types 1 and 2.
    Nishiyama Y; Kimura H; Daikoku T
    J Virol; 1991 Aug; 65(8):4520-4. PubMed ID: 1649347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Replication, latent infection, and reactivation in neuronal culture with a herpes simplex virus thymidine kinase-negative mutant.
    Wilcox CL; Crnic LS; Pizer LI
    Virology; 1992 Mar; 187(1):348-52. PubMed ID: 1310559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of encephalitis in adult mice induced by intracerebral inoculation of herpes simplex virus type 1 (KOS) and comparison with mutants showing decreased virulence.
    Chrisp CE; Sunstrum JC; Averill DR; Levine M; Glorioso JC
    Lab Invest; 1989 Jun; 60(6):822-30. PubMed ID: 2543866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A low thymidine kinase-producing mutant of herpes simplex virus type 1 causes latent trigeminal ganglia infections in mice.
    Gordon Y; Gilden DH; Shtram Y; Asher Y; Tabor E; Wellish M; Devlin M; Snipper D; Hadar J; Becker Y
    Arch Virol; 1983; 76(1):39-49. PubMed ID: 6305312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuronal control of herpes simplex virus latency.
    Tenser RB; Edris WA; Hay KA
    Virology; 1993 Aug; 195(2):337-47. PubMed ID: 8393231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral, neuronal and immune factors which may influence herpes simplex virus (HSV) latency and reactivation.
    Fraser NW; Valyi-Nagy T
    Microb Pathog; 1993 Aug; 15(2):83-91. PubMed ID: 8255209
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of herpes simplex virus type 1 thymidine kinase in pathogenesis.
    Efstathiou S; Kemp S; Darby G; Minson AC
    J Gen Virol; 1989 Apr; 70 ( Pt 4)():869-79. PubMed ID: 2543763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Herpes simplex virus neurovirulence and productive infection of neural cells is associated with a function which maps between 0.82 and 0.832 map units on the HSV genome.
    Thompson RL; Rogers SK; Zerhusen MA
    Virology; 1989 Oct; 172(2):435-50. PubMed ID: 2552657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance of peripheral autonomic neurons to in vivo productive infection by herpes simplex virus mutants deficient in thymidine kinase activity.
    Price RW; Khan A
    Infect Immun; 1981 Nov; 34(2):571-80. PubMed ID: 6273321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-galactosidase as a marker in the peripheral and neural tissues of the herpes simplex virus-infected mouse.
    Ho DY; Mocarski ES
    Virology; 1988 Nov; 167(1):279-83. PubMed ID: 2847416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Problems of herpes simplex virus latency.
    Klein RJ
    Antiviral Res; 1985; Suppl 1():111-20. PubMed ID: 3002250
    [No Abstract]   [Full Text] [Related]  

  • 18. Herpes simplex virus type 1 deletion variants 1714 and 1716 pinpoint neurovirulence-related sequences in Glasgow strain 17+ between immediate early gene 1 and the 'a' sequence.
    MacLean AR; ul-Fareed M; Robertson L; Harland J; Brown SM
    J Gen Virol; 1991 Mar; 72 ( Pt 3)():631-9. PubMed ID: 1848598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurovirulence and latency of drug-resistant clinical herpes simplex viruses in animal models.
    Dambrosi S; Martin M; Yim K; Miles B; Canas J; Sergerie Y; Boivin G
    J Med Virol; 2010 May; 82(6):1000-6. PubMed ID: 20419814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herpes simplex virus 1 mutant deleted in the alpha 22 gene: growth and gene expression in permissive and restrictive cells and establishment of latency in mice.
    Sears AE; Halliburton IW; Meignier B; Silver S; Roizman B
    J Virol; 1985 Aug; 55(2):338-46. PubMed ID: 2991560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.